Cordance Medical

United States - Mountain View, California

• 25/11/2025
• Seed
• $8,000,000

Cordance Medical is developing a focused ultrasound system that enables precision medicine to brain diseases. We accomplish this by opening the blood-brain barrier (BBB), extending life by accelerating drug approvals, and enabling liquid biopsy (blood) tests to provide a real-time view of the tumor biology. Our platform allows us to open the BBB precisely to physician-directed regions of the brain (e.g., tumor site, amyloid plaque) in a simple, non-invasive 30-minute clinic procedure. Extensive pre-clinical and clinical investigations have demonstrated the safety and efficacy of the focused ultrasound technology at opening the BBB. Cordance has developed a strong IP position enabling a painless, quick, and outpatient product deployment to meet the needs of the community. The company seeks to raise a seed round to fund the company through all pre-clinical activities enabling pivotal human studies next year. Our platform is applicable for glioblastoma (GBM), brain metastasis, Alzheimer's, Parkinson's, epilepsy and mental health.

Related People

Bhaskar RamamurthyFounder

United States - Mountain View, California

Experienced engineering leader with over 18 years of experience in the medical device industry in start-ups and large multi-national companies, including over 10 years of senior management with expertise in:
• Leading product development from concept to commercialization
• IP development, technology evaluation market assessment & development of strategic vision
• Providing strong functional, project, budget and resource management
• Managing regulatory and quality efforts
• Planning and leading clinical trials. Experienced as a Principal Investigator.

LinkedIn https://www.linkedin.com/in/bhaskar-ramamurthy-04a8264/